Computerized Screening

Medinteract brings you the first ever clinically proven, early warning Alzheimer's screening test, available online for your privacy and convenience.

COGselftest in JAD April 2010 Issue
Medinteract is pleased to announce that our Validation Study for the COGselftest (Computerized Self Test) was selected for publication in the April, 2010 issue of The Journal of Alzheimer's Disease (JAD). See the article...

Learn More



Learn about the COGselftest from the creator, Dr. John Dougherty, as well as from persons who have taken the test online.


Medinteract and Summit Medical Group Announce Rollout of Early Cognitive Impairment Screening Test

Medinteract’s COGselftest™ to be deployed through Summit Medical Group to improve early identification of cognitive impairment, including Alzheimer’s disease
Knoxville, TN – November 5, 2012 – Medical Interactive Education, LLC (Medinteract), a cognitive wellness company, and Summit Medical Group, a leading primary care provider, announced today that the Medinteract COGselftest (CST™) will begin to rollout in […]

Alzheimer’s Research in Tennessee – Dr. John Dougherty

Medinteract’s co-founder, Dr. John Dougherty and Dr. Alan Solomon from the University of Tennessee Medical Center, discuss the exciting research collaboration with Eli Lilly and Co. and the newly FDA-approved Amyvid which is used in the early diagnosis of mild cognitive impairment (MCI) and early Alzheimer’s disease.

Dr. Monica Crane Discusses Pat Summitt’s Impact on AD

Dr. Monica Crane, one of our advising physicians, recently spoke with WATE News about Pat Summitt’s impact on the Alzheimer’s community.